{
  "tool": "tavily",
  "query": "abridge company last_round_name",
  "results": [
    {
      "title": "Abridge - LinkedIn",
      "content": "Overview:\nAbridge was founded in 2018 with the mission of powering deeper understanding in healthcare. Our Best in KLAS AI-powered platform was purpose-built for medical conversations, improving clinical documentation efficiencies while enabling clinicians to focus on what matters most\u2014their patients. Our enterprise-grade technology transforms patient-clinician conversations into structured clinical notes in real-time, with deep EMR integrations. Powered by Linked Evidence and our purpose-built, auditable AI, we are the only company that maps AI-generated summaries to ground truth, helping providers quickly trust and verify the output. As pioneers in generative AI for healthcare, we are setting the industry standards for the responsible deployment of AI across health systems.\n\nWebsite: https://www.abridge.com/\nCrunchbase Url: https://www.crunchbase.com/organization/abridge-d1a4?utm_source=linkedin&utm_medium=referral&utm_campaign=linkedin_companies&utm_content=profile_cta_anon&trk=funding_crunchbase\nLinkedin Url: https://www.linkedin.com/company/abridgehq\n\nIndustry:\nHospitals and Health Care\n\nCompany size:\n201-500 employees\n445 associated members (LinkedIn members who\u2019ve listed Abridge as their current workplace on their profile)\n\nFounded:\n2018\n\nFunding:\nLast Round Date: 2025-07-24T00:00:00.000Z\nLast Round Type: Series E\nTotal Rounds: 9\nLast Round Raised: US$ 300.0M\n\nInvestors:\nKhosla Ventures, Andreessen Horowitz",
      "url": "https://www.linkedin.com/company/abridgehq"
    },
    {
      "title": "Abridge Inc - 2025 Company Profile, Team, Funding, Competitors ...",
      "content": "## Abridge Inc - About the company Abridge Inc is a series E company based in Pittsburgh (United States), founded in 2018byZachary Zack Lipton, Florian Metze, Shivdev Rao and Sandeep Konam. Abridge Inc has raised $773M in funding from investors like Lightspeed Venture Partners, Redpoint Ventures and Andreessen Horowitz, with a current valuation of $5.3B. | 1st | Abridge Inc 2018, Pittsburgh (United States), Series E | Provider of AI-based health record platform | $773M | IVP, CapitalG\u00a0&\u00a030\u00a0others | 70/100 | Abridge Inc is a funded company, having raised a total of $773M across 6 funding rounds to date. Abridge Inc's latest funding was a $316M Series E round on Jun 12, 2025, led byAndreessen Horowitz.",
      "url": "https://tracxn.com/d/companies/abridge-inc/__Pa9JE2faVUirY8e07Tb0M33vLUKKRf0BPr2xbtBzrq8"
    },
    {
      "title": "Abridge - Crunchbase Company Profile & Funding",
      "content": "Abridge is an AI-driven platform that transforms patient-clinician conversations into structured clinical notes for healthcare industries.",
      "url": "https://www.crunchbase.com/organization/abridge-d1a4"
    },
    {
      "title": "Healthcare startup Abridge raises $250 million to enhance AI ...",
      "content": "# Healthcare startup Abridge raises $250 million to enhance AI capabilities Feb 17 (Reuters) - Abridge, a startup that uses artificial intelligence to build medical documents, said on Monday it raised $250 million in a funding round co-led by Elad Gil and IVP. Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. AI startups captured a record 46.4% of the total $209 billion raised, opens new tab by U.S. startups in 2024, compared with less than 10% a decade earlier. The company was valued at $850 million after a funding round last year, in which it had raised $150 million. The healthcare startup said that the latest funding will help it develop AI capabilities and grow commercially.",
      "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/healthcare-startup-abridge-raises-250-million-enhance-ai-capabilities-2025-02-17/"
    },
    {
      "title": "Generative AI company Abridge scores $300M series E backed by ...",
      "content": "Expanding its gen AI tools to the inpatient setting opens up an entirely new surface area for innovation, Shiv Rao, M.D., Abridge CEO and a practicing cardiologist, told Fierce Healthcare last week The company's new capabilities and features represent how Abridge \"is going millions of miles deep\" on developing gen AI tools for different care settings and different clinical workflows, Rao told Fierce Healthcare. Abridge Andreessen Horowitz Khosla Ventures funding round venture capital (VC) electronic health records (EHRs) ambient AI generative AI Artificial Intelligence Revenue Cycle Management Finance Health Tech Hospitals Practices Providers AI and Machine Learning",
      "url": "https://www.fiercehealthcare.com/ai-and-machine-learning/ambient-ai-startup-abridge-scores-300m-series-e-backed-a16z-and-khosla"
    }
  ],
  "raw_content": "\nAbridge - LinkedIn\nOverview:\nAbridge was founded in 2018 with the mission of powering deeper understanding in healthcare. Our Best in KLAS AI-powered platform was purpose-built for medical conversations, improving clinical documentation efficiencies while enabling clinicians to focus on what matters most\u2014their patients. Our enterprise-grade technology transforms patient-clinician conversations into structured clinical notes in real-time, with deep EMR integrations. Powered by Linked Evidence and our purpose-built, auditable AI, we are the only company that maps AI-generated summaries to ground truth, helping providers quickly trust and verify the output. As pioneers in generative AI for healthcare, we are setting the industry standards for the responsible deployment of AI across health systems.\n\nWebsite: https://www.abridge.com/\nCrunchbase Url: https://www.crunchbase.com/organization/abridge-d1a4?utm_source=linkedin&utm_medium=referral&utm_campaign=linkedin_companies&utm_content=profile_cta_anon&trk=funding_crunchbase\nLinkedin Url: https://www.linkedin.com/company/abridgehq\n\nIndustry:\nHospitals and Health Care\n\nCompany size:\n201-500 employees\n445 associated members (LinkedIn members who\u2019ve listed Abridge as their current workplace on their profile)\n\nFounded:\n2018\n\nFunding:\nLast Round Date: 2025-07-24T00:00:00.000Z\nLast Round Type: Series E\nTotal Rounds: 9\nLast Round Raised: US$ 300.0M\n\nInvestors:\nKhosla Ventures, Andreessen Horowitz\n\nAbridge Inc - 2025 Company Profile, Team, Funding, Competitors ...\n## Abridge Inc - About the company Abridge Inc is a series E company based in Pittsburgh (United States), founded in 2018byZachary Zack Lipton, Florian Metze, Shivdev Rao and Sandeep Konam. Abridge Inc has raised $773M in funding from investors like Lightspeed Venture Partners, Redpoint Ventures and Andreessen Horowitz, with a current valuation of $5.3B. | 1st | Abridge Inc 2018, Pittsburgh (United States), Series E | Provider of AI-based health record platform | $773M | IVP, CapitalG\u00a0&\u00a030\u00a0others | 70/100 | Abridge Inc is a funded company, having raised a total of $773M across 6 funding rounds to date. Abridge Inc's latest funding was a $316M Series E round on Jun 12, 2025, led byAndreessen Horowitz.\n\nAbridge - Crunchbase Company Profile & Funding\nAbridge is an AI-driven platform that transforms patient-clinician conversations into structured clinical notes for healthcare industries.\n\nHealthcare startup Abridge raises $250 million to enhance AI ...\n# Healthcare startup Abridge raises $250 million to enhance AI capabilities Feb 17 (Reuters) - Abridge, a startup that uses artificial intelligence to build medical documents, said on Monday it raised $250 million in a funding round co-led by Elad Gil and IVP. Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. AI startups captured a record 46.4% of the total $209 billion raised, opens new tab by U.S. startups in 2024, compared with less than 10% a decade earlier. The company was valued at $850 million after a funding round last year, in which it had raised $150 million. The healthcare startup said that the latest funding will help it develop AI capabilities and grow commercially.\n\nGenerative AI company Abridge scores $300M series E backed by ...\nExpanding its gen AI tools to the inpatient setting opens up an entirely new surface area for innovation, Shiv Rao, M.D., Abridge CEO and a practicing cardiologist, told Fierce Healthcare last week The company's new capabilities and features represent how Abridge \"is going millions of miles deep\" on developing gen AI tools for different care settings and different clinical workflows, Rao told Fierce Healthcare. Abridge Andreessen Horowitz Khosla Ventures funding round venture capital (VC) electronic health records (EHRs) ambient AI generative AI Artificial Intelligence Revenue Cycle Management Finance Health Tech Hospitals Practices Providers AI and Machine Learning\n",
  "count": 5,
  "success": true
}